B. Riley Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

B. Riley Wealth Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-425	Closed	-$14	–	1452
2014 Q4	$14	Buy	+425	New	+$15.1K	﹤0.01%	2706
2014 Q3	–	Sell	-199	Closed	-$7.75K	–	1423
2014 Q2	$7.75K	Sell	199 -4,828	-96%	-$180K	﹤0.01%	1885
2014 Q1	$172K	Buy	+5,027	New	+$156K	0.05%	434

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

B. Riley Wealth Advisors's MYGN Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 425 shares — an estimated $14 sold.

B. Riley Wealth Advisors first reported a position in MYGN in Q1 2014 and held it in 3 quarters. The position peaked at $172K in Q1 2014. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

B. Riley Wealth Advisors reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 425 Myriad Genetics shares in Q1 2015, an estimated $14.
B. Riley Wealth Advisors first reported a position in Myriad Genetics in Q1 2014 and held it in 3 quarters.
B. Riley Wealth Advisors's Myriad Genetics position peaked at $172K in Q1 2014.
251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.